Zimmer Biomet Holdings (ZBH) Net Income towards Common Stockholders (2009 - 2026)

Zimmer Biomet Holdings' Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $238.3 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders rose 30.58% year-over-year to $238.3 million; the TTM figure through Mar 2026 stood at -$197.5 million (down 251.81% YoY), while the FY2025 annual figure was -$253.2 million, changed N/A from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at $238.3 million, up from -$820.4 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $419.7 million in Q4 2023, with the low at -$820.4 million in Q4 2025.
• The 5-year median for Net Income towards Common Stockholders is $196.2 million (2023), against an average of $76.6 million.
• The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders sank 1351.06% in 2022, then jumped 495.75% in 2023.
• Zimmer Biomet Holdings' Net Income towards Common Stockholders stood at -$58.8 million in 2022, then jumped by 813.78% to $419.7 million in 2023, then sank by 229.78% to -$544.7 million in 2024, then tumbled by 50.62% to -$820.4 million in 2025, then jumped by 129.05% to $238.3 million in 2026.
• Business Quant data shows ZBH's Net Income towards Common Stockholders at $238.3 million in Q1 2026, -$820.4 million in Q4 2025, and $231.2 million in Q3 2025.